Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$191.51 - $216.16 $4.12 Million - $4.65 Million
21,513 Added 57.26%
59,086 $12.5 Million
Q2 2023

Jul 28, 2023

BUY
$187.64 - $206.25 $2.38 Million - $2.62 Million
12,695 Added 51.03%
37,573 $7.23 Million
Q1 2023

May 11, 2023

BUY
$127.59 - $203.08 $28,962 - $46,099
227 Added 0.92%
24,878 $5.04 Million
Q4 2022

Jan 26, 2023

BUY
$117.37 - $139.17 $1.29 Million - $1.53 Million
10,991 Added 80.46%
24,651 $0
Q3 2022

Nov 10, 2022

SELL
$135.27 - $180.11 $187,348 - $249,452
-1,385 Reduced 9.21%
13,660 $1.87 Million
Q2 2022

Aug 09, 2022

SELL
$108.81 - $179.33 $458,307 - $755,337
-4,212 Reduced 21.87%
15,045 $2.66 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $256,922 - $339,061
2,148 Added 12.55%
19,257 $2.77 Million
Q4 2021

Jan 26, 2022

BUY
$142.57 - $190.86 $338,318 - $452,910
2,373 Added 16.1%
17,109 $2.65 Million
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $569 - $679
-4 Reduced 0.03%
14,736 $2.5 Million
Q2 2021

Aug 12, 2021

SELL
$135.08 - $161.1 $57,003 - $67,984
-422 Reduced 2.78%
14,740 $2.33 Million
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $40,702 - $56,476
296 Added 1.99%
15,162 $2.11 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $2.45 Million - $3.15 Million
14,866 New
14,866 $2.6 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.